Skip to main content
Fig. 2 | BMC Biotechnology

Fig. 2

From: Optimization of culture conditions for HBV-specific T cell expansion in vitro from chronically infected patients

Fig. 2

Differences in the amplification efficiency of various culture techniques. (A) Comparison of B + γ (20%, 1640 medium, human AB serum) and A + γ (total, 1640 medium, human AB serum) from 10 CHB patients. (B) Comparison of B + γ (20%, 1640 medium, human AB serum) and B + α (20%, AIM-V medium, human AB serum) from 10 CHB patients. (C) Comparison of B + β (20%, AIM-V medium, FBS) and B + α (20%, AIM-V medium, human AB serum) from 10 CHB patients. CHB, chronic hepatitis B; FBS, fetal bovine serum. P** < 0.01

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us